Catheter-Based Therapy for Atherosclerotic Renal Artery Stenosis

Progress in Cardiovascular Diseases

Volumn 50, Issue 2, 2007, Pages 136-150

  White, Christopher J ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; HEPARIN; HIRULOG; IODINATED CONTRAST MEDIUM;

ARTERIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIALYSIS; DISEASE COURSE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION; LUNG EDEMA; META ANALYSIS; NEPHROTOXICITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RENIN RELEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; STENT; SYSTEMATIC REVIEW;

ATHEROSCLEROSIS; CATHETERIZATION; HUMANS; RENAL ARTERY OBSTRUCTION;

EID: 34548359255     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.05.002     Document Type: Article

References (91)

1. Hansen K.J., Edwards M.S., Craven T.E., et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36 (2002) 443-451
2. Simon N., Franklin S., Bleifer K., et al. Clinical characteristics of renovascular hypertension. JAMA 220 (1972) 1209-1218
3. Guo H., Kalra P.A., Gilbertson D.T., et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 115 (2007) 50-58
4. Mailloux L.U., Napolitano B., Bellucci A.G., et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 24 (1994) 622-629
5. O'Neil E., Hansen K., Canzanello V., et al. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 58 (1992) 485-490
6. Uzu T., Inoue T., Fujii T., et al. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 29 (1997) 733-738
7. Rimmer J.M., and Gennari F.J. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118 (1993) 712-719
8. Slovut D.P., and Olin J.W. Fibromuscular dysplasia. N Engl J Med 350 (2004) 1862-1871
9. Scoble J. The epidemiology and clinical manifestations of atherosclerotic renal disease. In: Novick A.C., Scoble J.E., and Hamilton G. (Eds). Renal vascular disease (1996), W. B. Saunders, London 303-314
10. Jean W.J., Al-Bitar I., Zwicke D.L., et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 32 (1994) 8-10
11. Weber-Mzell D., Kotanko P., Schumacher M., et al. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 23 (2002) 1684-1691
12. Harding M.B., Smith L.R., Himmelstein S.I., et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 2 (1992) 1608-1616
13. Rihal C.S., Textor S.C., Breen J.F., et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 77 (2002) 309-316
14. Vetrovec G.W., Landwehr D.M., and Edwards V.I. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Interv Cardiol 2 (1989) 69-76
15. Valentine R., Myers S., Miller G., et al. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg 7 (1993) 220-224
16. Olin J., Melia M., Young J., et al. Prevalence of atherosclerosis renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88 (1990) 46N-51N
17. Caps M., Perissinotto C., Zierler R., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998) 2866-2872
18. Crowley J., Santos R., Peter R., et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 136 (1998) 913-918
19. van Jaarsveld B., Krijnen P., Pieterman H., et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med 342 (2000) 1007-1014
20. Conlon P.J., Little M.A., Pieper K., et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60 (2001) 1490-1497
21. Meaney T., Dustan H., and McCormack L. Natural history of renal arterial disease. Radiology 91 (1968) 881-887
22. Wollenweber J., Sheps S., and Davis G. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 21 (1968) 60-71
23. Schreiber M.J., Pohl M.A., and Novick A.C. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 11 (1984) 383-392
24. Greco B., and Breyer J. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?. Semin Nephrol 16 (1996) 2-11
25. Dean R., Kieffer R., Smith B., et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 116 (1981) 1408-1415
26. Zierler R., Bergelin R., Isaacson J., et al. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 19 (1994) 250-258
27. Rundback J.H., Sacks D., Kent K.C., et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 106 (2002) 1572-1585
28. De Bruyne B., Manoharan G., Pijls N.H., et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 48 (2006) 1851-1855
29. Radermacher J., Chavan A., Bleck J., et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344 (2001) 410-417
30. Zeller T., Muller C., Frank U., et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. CCI 58 (2003) 510-515
31. Garcia-Criado A., Gilabert R., Nicolau C., et al. Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med 24 (2005) 1641-1647
32. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47 (2006) 1239-1312
33. Plouin P.F., Chatellier G., Darne B., et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 31 (1998) 823-829
34. Webster J., Marshall F., Abdalla M., et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 12 (1998) 329-335
35. van de Ven P.J., Kaatee R., Beutler J.J., et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 353 (1999) 282-286
36. Weibull H., Bergqvist D., Bergentz S.E., et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 18 (1993) 841-850 (discussion 850-842)
37. Dorros G., Prince C., and Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn 29 (1993) 191-198
38. Sos T.A., Pickering T.G., Sniderman K., et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 309 (1983) 274-279
39. Rocha-Singh K., Jaff M.R., Rosenfield K., et al. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 46 (2005) 776-783
40. Nordmann A.J., Woo K., Parkes R., et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 114 (2003) 44-50
41. Isles C.G., Robertson S., and Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 92 (1999) 159-167
42. Leertouwer T.C., Gussenhoven E.J., Bosch J.L., et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 216 (2000) 78-85
43. Cioni R., Vignali C., Petruzzi P., et al. Renal artery stenting in patients with a solitary functioning kidney. Cardiovasc Intervent Radiol 24 (2001) 372-377
44. Sahin S., Cimsit C., Andac N., et al. Renal artery stenting in solitary functioning kidneys: technical and clinical results. Eur J Radiol 57 (2006) 131-137
45. Tan J., Filobbos R., Raghunathan G., et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant (2007) gfml30
46. Safian R.D., and Textor S.C. Renal-artery stenosis. N Engl J Med 344 (2001) 431-442
47. Watson P., Hadjipetrou P., Cox S., et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102 (2000) 1671-1677
48. Harden P., MacLeod M., Rodger R., et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet 349 (1997) 1133-1136
49. Zeller T., Frank U., Muller C., et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 108 (2003) 2244-2249
50. Rocha-Singh K.J., Ahuja R.K., Sung C.H., et al. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv 57 (2002) 135-141
51. Rocha-Singh K. Percutaneous renal artery intervention for preservation of renal function: strategies for identification of "at-risk" patients. Catheter Cardiovasc Interv 68 (2006) 507-512
52. Chabova V., Schirger A., Stanson A.W., et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 75 (2000) 437-444
53. Eggers P., Connerton R., McMullan M., et al. The Medicare experience with end-stage renal disease: trends and incidence, prevalence, and survival. Health Care Financ Rev 5 (1984) 69-88
54. White C.J., Jaff M.R., Haskal Z.J., et al. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation 114 (2006) 1892-1895
55. Muray S., Martin M., Amoedo M., et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 39 (2002) 60-66
56. Coen G., Moscaritolo E., Catalano C., et al. Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting. BMC Nephrol 5 (2004) 15
57. Leertouwer T.C., Derkx F.H., Pattynama P.M., et al. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int 62 (2002) 574-579
58. La Batide-Alanore A., Azizi M., Froissart M., et al. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol 12 (2001) 1235-1241
59. Shannon H.M., Gillespie I.N., and Moss J.G. Salvage of the solitary kidney by insertion of a renal artery stent. AJR Am J Roentgenol 171 (1998) 217-222
60. Bush R.L., Martin L.G., Lin P.H., et al. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. Ann Vasc Surg 15 (2001) 60-66
61. Chatziioannou A., Mourikis D., Agroyannis B., et al. Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg 23 (2002) 49-54
62. Khosla S., White C.J., Collins T.J., et al. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol 80 (1997) 363-366
63. Gray B., Olin J., Childs M., et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med 7 (2002) 275-279
64. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
65. Colyer Jr. W.R., Cooper C.J., Burket M.W., et al. Utility of a 0.014″ pressure-sensing guidewire to assess renal artery translesional systolic pressure gradients. Catheter Cardiovasc Interv 59 (2003) 372-377
66. Subramanian R., White C.J., Rosenfield K., et al. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv 64 (2005) 480-486
67. Mitchell J., Subramanian R., White C., et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement. CCI. 69 (2007) 685-689
68. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 17 (1991) 707-719
69. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
70. Lai K.N., Leung J.C., Yandle T.G., et al. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens 17 (1999) 575-583
71. Wiese S., Breyer T., Dragu A., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
72. Wolf K., Kurtz A., Pfeifer M., et al. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch 442 (2001) 212-217
73. Silva J.A., Chan A.W., White C.J., et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 111 (2005) 328-333
74. Blum U., Krumme B., Flugel P., et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. [see comments]. N Engl J Med 336 (1997) 459-465
75. Henry M., Amor M., Henry I., et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg 6 (1999) 42-51
76. Rocha-Singh K.J., Mishkel G.J., Katholi R.E., et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv 47 (1999) 167-172
77. Turtle K., Chouinard R., Webber J., et al. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis 33 (1999) 613-614
78. White C.J., Ramee S.R., Collins T.J., et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 30 (1997) 1445-1450
79. Lederman R., Mendelsohn F., Santos R., et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 142 (2001) 314-323
80. Bax L., Mali W.P., Van De Ven P.J., et al. Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 13 (2002) 1219-1224
81. Zeller T. Treatment of in-stent restenosis following stent-supported renal artery angioplasty. CCI (2007) [in press]
82. Hiramoto J., Hansen K.J., Pan X.M., et al. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg 41 (2005) 1026-1030
83. Henry M., Klonaris C., Henry I., et al. Protected renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther 8 (2001) 227-237
84. Henry M., Henry I., Klonaris C., et al. Renal angioplasty and stenting under protection: the way for the future?. Catheter Cardiovasc Interv 60 (2003) 299-312
85. Holden A., and Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 38 (2003) 962-968
86. Holden A., Hill A., Jaff M.R., et al. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 70 (2006) 948-955
87. Edwards M.S., Craven B.L., Stafford J., et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 44 (2006) 128-135
88. Cannon C.P., and Braunwald E. GUSTO, TIMI and the case for rapid reperfusion. Acta Cardiol 49 (1994) 1-8
89. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
90. Mulumudi M.S., and White C.J. Renal frame count: a quantitative angiographic assessment of renal perfusion. Catheter Cardiovasc Interv 65 (2005) 183-186
91. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 152 (2006) 59-66